Cargando…
Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion
The Coronavirus Disease 2019 (COVID-19) is rapidly spreading throughout the world after emerging in China in December 2019. Currently, there are no approved treatments for COVID-19 based on large clinical trial data, and hence, management involves infection prevention and control measures and suppor...
Autores principales: | Yamoah, Peter, Alalbila, Thelma Mpoku, Bangalee, Varsha, Oosthuizen, Frasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194243/ https://www.ncbi.nlm.nih.gov/pubmed/33258095 http://dx.doi.org/10.1007/s43441-020-00158-8 |
Ejemplares similares
-
Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess
por: Yamoah, Peter, et al.
Publicado: (2022) -
Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana
por: Yamoah, Peter, et al.
Publicado: (2019) -
A review of the safety of vaccines used in routine immunization in Africa
por: Yamoah, Peter, et al.
Publicado: (2020) -
Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana
por: Yamoah, Peter, et al.
Publicado: (2023) -
Antibiotic use amongst pregnant women in a public hospital in KwaZulu-Natal
por: Naidoo, Sasha, et al.
Publicado: (2021)